Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy

Not Recruiting

Trial ID: NCT03165188

Age - 18 Years-N/A Condition - Pancreatic Cancer Gender - All Accepting Healthy Volunteers - No

Purpose

This protocol (NLG0705) provides a mechanism for the 15-year follow-up period that the FDA requires for all participants in gene transfer protocols and assures that adequate follow-up can be maintained for subjects who have received at least one dose of algenpantucel-L.

Official Title

Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy

Stanford Investigator(s)

George A. Fisher Jr.
George A. Fisher Jr.

Colleen Haas Chair in the School of Medicine

Eligibility


Inclusion Criteria:

   - Receipt of at least one dose of algenpantucel-L within the past 15 years

   - Signed consent

View More
View Less

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Gino Pineda
650-725-8474

New Trial Alerts

©2024 Stanford Medicine